Literature DB >> 12049957

Comparing contrast-enhanced ultrasound to immunohistochemical markers of angiogenesis in a human melanoma xenograft model: preliminary results.

Flemming Forsberg1, Adam P Dicker, Mattew L Thakur, Nandkumar M Rawool, Ji-Bin Liu, William T Shi, Levon N Nazarian.   

Abstract

This study compared contrast-enhanced ultrasound (US) measures of tumor neovascularity with molecular markers of angiogenesis in a human melanoma xenograft model. A total of 14 mice were implanted with a human melanoma cell line (WM-9) in the thigh. After 2 to 3 weeks, a tumor, approximately 12 mm in diameter, developed. The US contrast agent Optison (Mallinckrodt, St. Louis, MO) was injected in a tail vein (dose: 0.4 to 0.6 mL/kg). Power Doppler and pulse-inversion harmonic imaging (HI) were performed with an Elegra scanner (Siemens Medical Systems, Issaquah, WA) and a 7.5 MHz linear array. Frame-rates of 30 Hz and 0.5 Hz (intermittent imaging) were used for pulse-inversion HI. After surgical removal, specimens were sectioned in the same planes as the US images. Immunohistochemical stains for endothelial cells (CD31), vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and cyclooxygenase-2 (COX-2) were performed. Two observers graded the stains (for intensity and percent area), and two other observers graded the US imaging modes (for fractional tumor neovascularity) on the same scale from 0 to 3. Of the 14 mice, 4 failed for technical reasons (i.e., n = 10). Linear regressions indicated statistically significant correlations between percent area stained with COX-2 and power Doppler (r = -0.789; p < 0.01), as well as intermittent pulse-inversion HI (r = -0.795; p < 0.05). There was a trend toward significance between percent area stained with VEGF and intermittent pulse-inversion HI (r = -0.720; 0.05 < p < 0.10). No other comparisons were significant. In conclusion, contrast-enhanced US measures of tumor neovascularity in a human melanoma xenograft model appear to provide a noninvasive marker of angiogenesis corresponding to expression of COX-2. However, the sample size of this study is small and, until further studies have been conducted, these conclusions are preliminary.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12049957     DOI: 10.1016/s0301-5629(02)00482-9

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  14 in total

1.  [Quantification of tissue perfusion with novel ultrasound methods].

Authors:  M Krix; H-U Kauczor; S Delorme
Journal:  Radiologe       Date:  2003-10       Impact factor: 0.635

2.  Quantitative evaluation of contrast-enhanced ultrasound after intravenous administration of a microbubble contrast agent for differentiation of benign and malignant thyroid nodules: assessment of diagnostic accuracy.

Authors:  Ursula Nemec; Stefan F Nemec; Clemens Novotny; Michael Weber; Christian Czerny; Christian R Krestan
Journal:  Eur Radiol       Date:  2012-02-10       Impact factor: 5.315

Review 3.  Contrast-enhanced ultrasound for molecular imaging of angiogenesis.

Authors:  J R Eisenbrey; F Forsberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

Review 4.  [Vascular imaging with contrast-enhanced sonography for experimental use].

Authors:  M Krix; H-U Kauczor; S Delorme
Journal:  Radiologe       Date:  2005-06       Impact factor: 0.635

5.  Comparing contrast-enhanced color flow imaging and pathological measures of breast lesion vascularity.

Authors:  Flemming Forsberg; Babita Kuruvilla; Mark B Pascua; Manisha H Chaudhari; Daniel A Merton; Juan P Palazzo; Barry B Goldberg
Journal:  Ultrasound Med Biol       Date:  2008-04-24       Impact factor: 2.998

Review 6.  Molecular imaging in clinical trials.

Authors:  Debra Josephs; James Spicer; Michael O'Doherty
Journal:  Target Oncol       Date:  2009-09-21       Impact factor: 4.493

7.  Correlation of ultrasound contrast agent derived blood flow parameters with immunohistochemical angiogenesis markers in murine xenograft tumor models.

Authors:  John R Eisenbrey; Christian C Wilson; Raymond J Ro; Traci B Fox; Ji-Bin Liu; See-Ying Chiou; Flemming Forsberg
Journal:  Ultrasonics       Date:  2013-04-12       Impact factor: 2.890

8.  Quantitative mapping of tumor vascularity using volumetric contrast-enhanced ultrasound.

Authors:  Kenneth Hoyt; Anna Sorace; Reshu Saini
Journal:  Invest Radiol       Date:  2012-03       Impact factor: 6.016

Review 9.  Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering.

Authors:  Shengping Qin; Charles F Caskey; Katherine W Ferrara
Journal:  Phys Med Biol       Date:  2009-02-19       Impact factor: 3.609

10.  A molecular imaging paradigm to rapidly profile response to angiogenesis-directed therapy in small animals.

Authors:  John Virostko; Jingping Xie; Dennis E Hallahan; Carlos L Arteaga; John C Gore; H Charles Manning
Journal:  Mol Imaging Biol       Date:  2009-01-07       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.